Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending October 7, 2022

Drug Industry TRx: +3.0% w/w; +7.6% y/y

Vascepa
TRx 64,478; +2.8% (+1,775) w/w; -20.5% y/y
NRx 29,602; +2.7% (+777) w/w; -19.2% y/y
Ref 34,876; +2.9% (+997) w/w; -21.5% y/y

Fake Vascepa
TRx 40,157; +2.5% (+980) w/w; As % of total V: 38.4%
NRx 19,796; +3.3% (+635) w/w; As % of total V: 40.1%
Ref 20,361; +1.7% (+344) w/w; As % of total V: 36.9%

Fake Vascepa by Manufacturer
Hikma - TRx 13,997; (+381) w/w; Generic share 34.9%; Total V share 13.4%
Reddy - TRx 18,641; (+487) w/w; Generic share 46.4%; Total V share 17.8%
Apotex - TRx 7,354; (+31) w/w; Generic share 18.3%; Total V share 7.0%
Teva - TRx 165; (+81) w/w; Generic share 0.4%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 104,635; +2.7% (+2,754) w/w; +5.4% y/y
NRx 49,397; +2.9% (+1,413) w/w; +3.8% y/y
Ref 55,238; +2.5% (+1,342) w/w; 5.0% y/y

Lovaza (Fake & Brand)
TRx 64,301; +4.3% (+2,668) w/w; -0.3% y/y
NRx 30,879; +2.4% (+724) w/w; -1.8% y/y
Ref 33,422; +6.2% (+1,944) w/w; +1.2% y/y